Energy-requiring uptake of prostasomes and PC3 cell-derived exosomes into non-malignant and malignant cells

Journal of Extracellular Vesicles

Volumn 5, Issue 1, 2016, Pages

  Ronquist, Karl Göran ^a   Sanchez, Claire ^b   Dubois, Louise ^a   Chioureas, Dimitris ^b   Fonseca, Pedro ^b   Larsson, Anders ^a   Ullén, Anders ^b   Yachnin, Jeffrey ^b   Ronquist, Gunnar ^a   Panaretakis, Theocharis ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ATPase; energy metabolism; exosome uptake; exosomes; extracellular ATP; extracellular vesicles; glycolysis; prostasomes; prostate cancer

Indexed keywords

ADENOSINE TRIPHOSPHATASE; GLYCOLYTIC ENZYME;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRL2221 CELL LINE; ENERGY CONSUMPTION; ENERGY TRANSFER; ENZYME ACTIVITY; EXOSOME; GLYCOLYSIS; HUMAN; HUMAN CELL; INTERNALIZATION; PC3 CELL LINE; PROSTATE CANCER CELL LINE; PROSTATE EPITHELIUM CELL; PROTEOMICS;

EID: 84994661190     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v5.29877     Document Type: Article

References (37)

1. Ronquist G, Hedstrom M. Restoration of detergent-inactivated adenosine triphosphatase activity of human prostatic fluid with concanavalin A. Biochim Biophys Acta. 1977; 483: 483–6.
2. Ronquist G. Prostasomes are mediators of intercellular communication: from basic research to clinical implications. J Intern Med. 2012; 271: 400–13.
3. Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta. 1985; 822: 203–18.
4. Sahlen GE, Egevad L, Ahlander A, Norlen BJ, Ronquist G, Nilsson BO. Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate. Prostate. 2002; 53: 192–9.
5. Park KH, Kim BJ, Kang J, Nam TS, Lim JM, Kim HT, etal. Ca2+ signaling tools acquired from prostasomes are required for progesterone-induced sperm motility. Sci Signal. 2011; 4: ra31.
6. Ronquist GK, Larsson A, Ronquist G, Isaksson A, Hreinsson J, Carlsson L, etal. Prostasomal DNA characterization and transfer into human sperm. Mol Reprod Dev. 2011; 78: 467–76.
7. Ronquist GK, Larsson A, Stavreus-Evers A, Ronquist G. Prostasomes are heterogeneous regarding size and appearance but affiliated to one DNA-containing exosome family. Prostate. 2012; 72: 1736–45.
8. Aalberts M, van Dissel-Emiliani FM, van Adrichem NP, van Wijnen M, Wauben MH, Stout TA, etal. Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol Reprod. 2012; 86: 82.
9. Llorente A, de Marco MC, Alonso MA. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. J Cell Sci. 2004; 117(Pt 22):5343–51.
10. Ronquist KG, Carlsson L, Ronquist G, Nilsson S, Larsson A. Prostasome-derived proteins capable of eliciting an immune response in prostate cancer patients. Int J Cancer. 2006; 119: 847–53.
11. Dubois L, Ronquist KG, Ek B, Ronquist G, Larsson A. Proteomic profiling of detergent resistant membranes (lipid rafts) of prostasomes. Mol Cell Proteomics. 2015; 14: 3015–22.
12. Arvidson G, Ronquist G, Wikander G, Ojteg AC. Human prostasome membranes exhibit very high cholesterol/phospholipid ratios yielding high molecular ordering. Biochim Biophys Acta. 1989; 984: 167–73.
13. Brouwers JF, Aalberts M, Jansen JW, van Niel G, Wauben MH, Stout TA, etal. Distinct lipid compositions of two types of human prostasomes. Proteomics. 2013; 13: 1660–6.
14. Ronquist KG, Ek B, Morrell J, Stavreus-Evers A, Strom Holst B, Humblot P, etal. Prostasomes from four different species are able to produce extracellular adenosine triphosphate (ATP). Biochim Biophys Acta. 2013; 1830: 4604–10.
15. Drake RR, Kislinger T. The proteomics of prostate cancer exosomes. Expert Rev Proteomics. 2014; 11: 167–77.
16. Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, etal. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget. 2015; 6: 21740–54.
17. Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, etal. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene. 2015; 34: 290–302.
18. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011; 11: 85–95.
19. Ronquist KG, Ek B, Stavreus-Evers A, Larsson A, Ronquist G. Human prostasomes express glycolytic enzymes with capacity for ATP production. Am J Physiol Endocrinol Metab. 2013; 304: E576–82.
20. Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics. 2009; 9: 4997–5000.
21. Ronquist G. Zinc ion stimulation of ATP cleavage by prostasomes from human seminal plasma. Urol Int. 1988; 43: 334–40.
22. Ronquist G. Effect of modulators on prostasome membrane-bound ATPase in human seminal plasma. Eur J Clin Invest. 1987; 17: 231–6.
23. Nilsson BO, Jin M, Einarsson B, Persson BE, Ronquist G. Monoclonal antibodies against human prostasomes. Prostate. 1998; 35: 178–84.
24. Harma V, Virtanen J, Makela R, Happonen A, Mpindi JP, Knuuttila M, etal. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One. 2010; 5: e10431.
25. Nyga A, Cheema U, Loizidou M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal. 2011; 5: 239–48.
26. Dubois L, Stridsberg M, Kharaziha P, Chioureas D, Meersman N, Panaretakis T, etal. Malignant cell-derived extracellular vesicles express different chromogranin epitopes compared to prostasomes. Prostate. 2015; 75: 1063–73.
27. Pankiewicz KW. Novel nicotinamide adenine dinucleotide analogues as potential anticancer agents: quest for specific inhibition of inosine monophosphate dehydrogenase. Pharmacol Ther. 1997; 76: 89–100.
28. Floryk D, Tollaksen SL, Giometti CS, Huberman E. Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5’-monophosphate dehydrogenase. Cancer Res. 2004; 64: 9049–56.
29. Agren G, Ponten J, Ronquist G, Westermark B. Demonstration of an ATPase at the cell surface of intact normal and neoplastic human cells in culture. J Cell Physiol. 1971; 78: 171–6.
30. Hattori M, Gouaux E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature. 2012; 485: 207–12.
31. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991; 266: 17707–12.
32. Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M, etal. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011; 124(Pt 3):447–58.
33. Stegmayr B, Brody I, Ronquist G. A biochemical and ultrastructural study on the endogenous protein kinase activity of secretory granule membranes of prostatic origin in human seminal plasma. J Ultrastruct Res. 1982; 78: 206–14.
34. Agren G, Ronquist G. (32-P) Phosphoryl transfer by endogenous protein kinase at the glia and glioma cell surface in culture into extrinsic acceptor proteins. Acta physiol Scand. 1974; 92: 430–2.
35. Boyce AK, Kim MS, Wicki-Stordeur LE, Swayne LA. ATP stimulates pannexin 1 internalization to endosomal compartments. Biochem J. 2015; 470: 319–30.
36. White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci. 2006; 27: 211–7.
37. Roger S, Pelegrin P. P2X7 receptor antagonism in the treatment of cancers. Expert Opin Investig Drugs. 2011; 20: 875–80.